JG

Jyoti Gupta

Active Director Director DIN 09482863
DIN 09482863 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Jyoti Gupta

Data last updated:

Jyoti Gupta is a Director at Evanex Skin Health Private Limited (since 2022). The company operates in Chemicals. Evanex Skin Health Private Limited reported revenue of ₹17.6 Lakh (FY 2025).

DIN 09482863
Primary Designation Director
Industry Chemicals
First Appointment 28 Jan 2022
Oldest Company Age 4 yrs
Largest company Evanex Skin Health Private Limited · ₹17.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evanex Skin Health Private Limited U24246MP2022PTC059309
Director28 Jan 20222022₹17.6 Lakh (FY 2025)Active

Board colleagues of Jyoti Gupta

Directorship timeline

Open interactive timeline →
Evanex Skin Health Private Limited
Premium access

Shareholding and investment profile for Jyoti Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Gupta

Jyoti Gupta currently holds 1 directorship: Evanex Skin Health Private Limited (Director, since 28 Jan 2022, revenue ₹17.6 Lakh (FY 2025)).

Jyoti Gupta was first appointed on 28 Jan 2022 as Director at Evanex Skin Health Private Limited.

The current boards of Jyoti Gupta's companies include Nitin Agrawal (Evanex Skin Health Private Limited), Vipin Agrawal (Evanex Skin Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available